Custom Index Systems LLC Sells 34 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Custom Index Systems LLC cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 784 shares of the medical equipment provider’s stock after selling 34 shares during the quarter. Custom Index Systems LLC’s holdings in Intuitive Surgical were worth $385,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Creekmur Asset Management LLC grew its position in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares during the period. Ridgewood Investments LLC acquired a new stake in Intuitive Surgical in the 2nd quarter valued at about $26,000. Delos Wealth Advisors LLC grew its holdings in Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares during the period. Godsey & Gibb Inc. increased its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the last quarter. Finally, LRI Investments LLC bought a new stake in Intuitive Surgical in the first quarter valued at approximately $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 2,943 shares of the firm’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, EVP Robert Desantis sold 240 shares of the company’s stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,558,968.56. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Amal M. Johnson sold 2,943 shares of the stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 51,816 shares of company stock worth $25,230,649 over the last three months. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Mizuho lifted their target price on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Piper Sandler reaffirmed an “overweight” rating and set a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research report on Friday, October 18th. Truist Financial lifted their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a report on Monday, October 14th. Finally, Citigroup increased their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Trading Down 0.1 %

Shares of Intuitive Surgical stock opened at $511.27 on Monday. The company has a market cap of $182.10 billion, a PE ratio of 82.20, a price-to-earnings-growth ratio of 5.11 and a beta of 1.39. The company has a 50 day moving average of $487.98 and a 200-day moving average of $443.05. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $523.34.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.